The results were quite surprising. They found that people who took GLP-1 agonists had a 30% lower risk of developing dementia ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Most current drugs for obesity and diabetes, like liraglutide, target a hormone receptor known as GLP-1. These medications ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

A recent study led by scientists at the University of Florida suggests that two classes of diabetes drugs—GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is)—could lower the risk ...

A class of older drugs used to treat type 2 diabetes may also help slow the progression of prostate cancer, a small study suggests.

The following is a summary of “Investigating socioeconomic disparities in prescribing new diabetes medications in individuals ...

A new class of drugs called GLP-1 agonists, originally developed to control blood sugar in patients with type 2 diabetes, have been found highly effective for weight loss as well. Although the ...